Scientists track rare muscle disease to pave way for future treatments
NCT ID NCT03842878
Summary
This study aimed to better understand how Limb-Girdle Muscular Dystrophy 2I (LGMD2I) progresses over time. Researchers followed 52 patients for up to 2 years, measuring their walking ability, muscle strength, heart function, and overall mobility. The goal was to gather detailed information about the disease's course to help design better future treatment trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LGMD2I are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr Tanya Stojkovic
Paris, 75013, France
-
Pr John Vissing
Copenhagen, DK-2100, Denmark
-
Pr Volker Straub
Newcastle, NE1 3BZ, United Kingdom
Conditions
Explore the condition pages connected to this study.